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Abstract
Background: Protein cross-linking which occurs towards the latter part of protein glycation is implicated in the
development of chronic diabetic complications. Glycation induced protein cross-linking inhibitory effects of nine
antidiabetic plants and three spices were evaluated in this study using a novel, simple, electrophoresis based method.
Methods: Methanol extracts of thirteen plants including nine antidiabetic plants and three spices were used. Lysozyme
and fructose were incubated at 37 °C in the presence or absence of different concentrations of plant extracts up to
31 days. Standard glycation inhibitor aminoguanidine and other appropriate controls were included. A recently
established sodium dodecyl polyacrylamide gel electrophoresis (SDS-PAGE) method was used to detect the products
of protein cross-linking in the incubation mixtures.
Results: High molecular weight protein products representing the dimer, trimer and tetramer of lysozyme were
detected in the presence of fructose. Among the nine antidiabetic plants, seven showed glycation induced protein
cross-linking inhibitory effects namely Ficus racemosa (FR) stem bark, Gymnema sylvestre (GS) leaves, Musa paradisiaca
(MP) yam, Phyllanthus debilis (PD) whole plant, Phyllanthus emblica (PE) fruit, Pterocarpus marsupium (PM) latex and
Tinospora cordifolia (TC) leaves. Inhibition observed with Coccinia grandis (CG) leaves and Strychnos potatorum (SP) seeds
were much low. Leaves of Gymnema lactiferum (GL), the plant without known antidiabetic effects showed the lowest
inhibition. All three spices namely Coriandrum sativum (CS) seeds, Cinnamomum zeylanicum (CZ) bark and Syzygium
aromaticum (SA) flower buds showed cross-link inhibitory effects with higher effects in CS and SA. PD, PE, PM, CS and
SA showed almost complete inhibition on the formation of cross-linking with 25 μg/ml extracts.
Conclusions: Methanol extracts of PD, PE, PM, CS and SA have shown promising inhibitory effects on glycation
induced protein cross-linking.
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Background
Global prevalence of diabetes mellitus is rising with a
particularly high increase of prevalence in developing
countries [1]. Diabetes is associated with serious chronic
complications such as retinopathy, nephropathy and car-
diovascular diseases. A non-enzymatic process known as
glycation, is accelerated as a result of persistently ele-
vated plasma glucose levels occur in diabetic patients.
Protein glycation has a primary role in the development
of chronic diabetic complications [2, 3]. Hyperglycaemia
accelerates the formation of covalent adducts with vari-
ous structural and functional proteins such as collagen
and albumin through glycation. The cells such as vascu-
lar endothelial cells and renal mesangial cells express
high levels of the glucose transporter 1 and are more
susceptible for complications associated with hypergly-
caemia [4].
Over a period of time, glycation products form a com-
plex family of stable heterogeneous group of compounds
called advanced glycation end-products (AGEs) causing
irreversible structural and functional damage to the af-
fected protein molecules. Through various interlinked
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pathways, AGEs result in endothelial dysfunction leading
to vasoconstriction, change in the endothelial surface in
to a procoagulant surface, chemotaxis of macrophages
and increased phagocytosis of modified lipids culmina-
ting in the formation of atherosclerotic plaques leading
to macrovascular complications. Interaction of AGEs
with receptors for advanced glycation end products
(RAGE) induces the synthesis and release of cytokines
which mediate enhanced production of collagen, lami-
nin, and fibronectin leading to fibrosis [5].
Some AGEs are associated with inter or intra molecular
covalent cross-links leading to adverse effects [6]. Cross-
linked AGEs can be divided into fluorescent cross-linked
AGEs such as glucosepane, pentosidine, crossline, glyoxal-
derived lysine dimer (GOLD), methylglyoxal lysine dimer
(MOLD) and non-fluorescent cross-linked AGEs such as
imidazolium dilysine, alkyl formyl glycosyl pyrrole cross-
links and arginine-lysine imidazole cross-links [4]. Devas-
tating effects occur when protein cross-links are formed
in long-lived proteins. Collagen being a major component
of the extra cellular matrix and the longest lived protein in
higher animals becomes a key target of glycation induced
cross-linking [4]. Collagen is a major component of the
blood vessels and in the framework of most of the paren-
chymal organs. Collagen is continuously exposed to glu-
cose in vascular and extra vascular fluids [4]. Glycation
induced cross-linking results in decreased vascular elasti-
city and reduced vascular compliance [5]. Cross-linking
increases the rigidity of collagen and reduces its flexibility
and susceptibility to enzymatic digestion leading to thic-
kening of basement membranes as observed in micro-
vascular lesions such as nephropathy [4].
Inhibition of glycation induced protein cross-linking is
one of the therapeutic approaches that delay or prevent
the progression of diabetic complications. A number of
compounds recognized with potential glycation inhibitory
effects including the extensively studied aminoguanidine
(AG), failed at clinical trials due to their side-effects [7].
Recent studies have highlighted the importance of using
plants with antiglycation properties [8] which may offer
gentle and safe means of managing glycation induced mo-
lecular damage. Plants with antidiabetic effects are being
used in traditional medicine for thousands of years with-
out side effects. Spices are consumed in the daily diet as
additives to improve the flavour of the food. A few studies
have reported antiglycation effects of some medicinal
plants using expensive specialized techniques such as high
performance liquid chromatography, mass spectrometry,
fluorescence spectrometry and specific ELISA assays [9].
However, only a minor fraction of these medicinal plants
are scientifically validated for glycation induced protein
cross-linking inhibitory effects.
In this study, the glycation induced protein cross-
linking inhibitory effects of nine antidiabetic plants and
three spices were evaluated, using a novel, simple, elec-




Parts from ten plants including nine antidiabetic plants
were collected from Ratnapura District, Sri Lanka, namely,
Coccinia grandis (L.) J. Voigt (Kowakka) (CG) leaves, Ficus
racemosa L. (Attikka) (FR) stem bark, Gymnema lactiferum
(L.) R. Br. ex Schult (Kurinnan) (GL) leaves, Gymnema
sylvestre (Retz.) R. Br. Ex Schult (Masbedda) (GS) leaves,
Musa X paradisiaca L. (Alu kesel) (MP) yam, Phyllanthus
debilis Klein ex Willd (Pitawakka) (PD) whole plant, Phyl-
lanthus emblica L. (Nelli) (PE) fruit, Pterocarpus marsu-
pium Roxb. (Gammalu) (PM) latex, Strychnos potatorum
L. f. (Ingini) (SP) seeds and Tinospora cordifolia (Willd.)
Hook.f & Thoms. (Rasakinda) (TC) leaves. Plants were
authenticated (HKIP-CSH-2013-01 to HKIP-CSH-2013-10)
and the voucher samples were deposited at the Royal
Botanical Gardens, Peradeniya, Sri Lanka. Plant parts were
cleaned, shade dried for approximately 1 week and pow-
dered. Dried latex of P. marsupium was used without fur-
ther processing.
Spices
Dried Coriandrum sativum (Coriander) (CS) seeds, Cinna-
momum zeylanicum (Cinnamon) (CZ) bark and Syzygium
aromaticum (Clove) (SA) flower buds were purchased as
branded products from the open market.
Preparation of methanol extracts
Plant parts were cleaned and powdered using a grinder.
Dry powder (10 g) was extracted three times with me-
thanol (100 ml) using a sonicator. Methanol extract was
filtered and the solvent was evaporated by rotary evapor-
ator (Buchi RII) at 45-50 °C. Dry methanol extracts were
stored at room temperature until further analysis. Ex-
tracts and PM latex were resuspended in phosphate
buffer (pH 7.4) to the required working concentrations
before the experiments. Plant concentrations used in the
reaction mixture were 1 to 5 mg/ml for initial screening.
Concentration was reduced up to 5 or 1 μg/ml to assess
the cross-link inhibitory effect of extracts which have
shown strong inhibitory effects.
Detection of glycation induced protein cross-linking
A method developed to detect the inhibitory effects of
plant extracts on protein cross-linking was used [10].
Briefly, working solutions of chicken egg lysozyme
(Sigma), fructose and plant extracts were prepared using
200 mM phosphate buffer (pH 7.4) containing 0.02 %
sodium azide. Lysozyme and fructose (500 mM) was in-
cubated in the presence of plant extracts for up to
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31 days at 37 °C. Final concentration of the plant ex-
tracts used for initial screening was 5 mg/ml and the
concentration was reduced to 100, 50, 25, 5 or 1 μg/ml
with the extracts that showed higher cross-link inhibi-
tory effects. Standard inhibitor AG (Sigma) [10 mM
(1.1 mg/ml)] was included as the positive control. A
control was prepared with buffer, lysozyme and fructose.
Corresponding blanks for tests and controls were pre-
pared without fructose. Aliquots were collected at inter-
vals (three times during the first week (i.e. Day 1, 2, 6 or 7)
and two times thereafter until day 31 (i.e. Day 10, 14, 17,
21, 26, 31) and stored at −40 °C until further analysis.
These aliquots were analyzed for the appearance of
high molecular weight products using sodium dodecyl
polyacrylamide gel electrophoresis (SDS-PAGE). SDS-
polyacrylamide gels (12 %) were prepared according to the
standard Laemmli procedure [11]. Aliquots from the incu-
bation mixtures were heated with the SDS sample buffer
at 95 °C for 3 min, before loading to the gel [11]. Broad
range molecular weight markers (10–225 kDa) (Promega)
were used to assess the approximate size of the high
molecular weight products. Electrophoresis was carried
out using Enduro Vertical Gel Electrophoresis system-
E2010-P according to the standard Laemmli method [11].
After separation at pH 8.6, protein bands were visualized
by staining with Coomassie brilliant blue. Appearance of
high molecular weight products of lysozyme was assessed
by visual observation.
All the experiments were repeated three times or more.
Results
Percentage yield of plant extracts
Percentage yield of methanol extracts were CG 6.36, FR
45.36, GL 15.45, GS 13.00, MP 2.00, PE 33.33, PD 20.09,
SP 27.48 and TC 6.39. Higher yield with methanol was
observed with bark, fruit (with seed) and seed. Lowest
yield was observed with MP yam.
Detection of glycation induced protein cross-linking
SDS-PAGE of aliquots collected at various intervals of
incubation in the presence or absence of plant extracts
were compared. Molecular weight of the lysozme was
approximately 12 KDa. High molecular weight protein
products were formed when lysozyme was incubated
with fructose (Figs. 1, 2, 3, 4, 5). Such products were not
observed in the absence of fructose (Figs. 2, 4).
Cross-linked lysozyme was observed as high molecular
weight bands. Those products represented the dimer
(~24 KDa), trimer (~36 KDa) and tetramer (~48 KDa) of
lysozyme when compared with the size of the unglycated
lysozyme (~12 KDa) (Fig. 1a). Appearance of high mo-
lecular weight products gradually increased over time
from day 1 to 6 (Fig. 1b). On day 1 only the dimer was
observed (Fig. 1b).
Detection of glycation induced protein cross-linking
inhibitory potential of antidiabetic plants
In the absence of fructose (- Fructose) there was no in-
crease in the appearance of high molecualr weight prod-
ucts (Fig. 2a). When compared with the unhibited
control (−P), there was almost complete inhibition of
glycation induced protein cross-linking in the presence
of the extracts of FR, GS, MP, PD, PE, PM and TC dur-
ing initial screening with 5 mg/ml extracts (Fig. 2b). This
inhibition was observed on day 7 and persisted even at
the later parts (Day 26) of the incubation (Fig. 2b).
Lesser degree of inhibition of cross-linking was observed
with 5 mg/ml extracts of CG and SP on day 7 (Fig. 2b).
Amount of high molecular weight products observed
with GL was close to that of uninhibited control (−P)
indicating lack of inhibitory effects (Fig. 2b). Standard
inhibitor AG showed almost complete inhibition of cross-
linking on day 7 (Fig. 2b). However AG showed a lesser
degree of inhibition of cross-linking on day 26 (Fig. 2b).
Fig. 1 Formation of high molecular weight products in the presence
of fructose. a Formation of protein cross-links in presence of fructose.
SDS-PAGE was conducted with the aliquots collected at day 6. MW:
Molecular weight markers, −P: in the presence of fructose without
plant extracts or AG. This observation was made on varying incubation
periods for more than 100 times. b Progress of protein cross-linking
over time in the presence of fructose. SDS-PAGE was conducted with
the aliquots collected at day 1 (D1), day 2 (D2) and day 6 (D6) from
lysozyme incubated with fructose in absence of plant extracts or AG.
Experiment was repeated three times
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Fig. 2 Effect of antidiabetic plants at 5 mg/ml on glycation induced protein cross-linking. SDS-PAGE was conducted using aliquots collected on
day 7 (top) and day 26 (bottom). a Incubations carried out without fructose (−Fructose). b Incubations carried out with fructose (+ Fructose). -P: in the
absence of plant extracts or AG, AG: Aminoguanidine, CG: C. grandis, FR: F. racemosa, GL: G. lactiferum, GS: G. sylvestre, MP: M. paradisiaca, PE: P. emblica,
PD: P. debilis, PM: P. marsupium, SP: S. potatorum, TC: T. Cordifolia. Experiment was repeated three times
Fig. 3 Effect of antidiabetic plants at 2.5 or 0.1 mg/ml on glycation induced protein cross-linking. SDS-PAGE was conducted using aliquots collected
after 6 days. Incubations were carried out in the presence of fructose with different plant extracts. PE, PD and PM were used at 0.1 mg/ml. Rest of the
plant extracts were used at 2.5 mg/ml. -P: in the absence of plant extracts or AG, AG: Aminoguanidine, CG: C. grandis, FR: F. racemosa, GL: G. lactiferum,
GS: G. sylvestre, MP: M. paradisiaca, PE: P. emblica, PD: P. debilis, PM: P. marsupium, SP: S. potatorum, TC: T. Cordifolia. Experiment was repeated three times
Perera and Handuwalage BMC Complementary and Alternative Medicine  (2015) 15:175 Page 4 of 9
When 2.5 mg/ml extracts were used FR, GS, MP and TC
showed almost complete inhibition (Fig. 3). These four ex-
tracts were not tested with lower concentrations in this
study. CG and SP showed a low level of inhibition at
2.5 mg/ml. No inhibition was observed with GL at this
concentration.
Lower concentrations of PD, PE and PM were used to
investigate the inhibitory effects further. Almost complete
inhibition of cross-linking was observed with 0.1 mg/ml ex-
tracts (Fig. 3). Inhibition of protein cross-linking was almost
complete, even with 25 μg/ml PD, PE and PM showing evi-
dence for strong glycation induced protein cross-linking
Fig. 5 Effect of PE, PD, PM, CS and SA at lower concentrations on glycation induced protein cross-linking. a: Glycation induced protein cross-linking
inhibitory potential of PE and PD. SDS-PAGE was conducted using aliquots collected after 17 days. Incubations were carried out in the presence of
fructose without plant extracts or AG (−P) or with PE: P. emblica and PD: P. debilis at 5, 25 and 50 μg/ml. Experiment was repeated four times. b: Glycation
induced protein cross-linking inhibitory potential of PM, CS and SA. SDS-PAGE was conducted using aliquots collected after 4 days (Additional file 1).
Incubations were carried out in the presence of fructose without plant extracts (−P) or with 5 and 25 μg/ml, PM: P. marsupium, CS: C. sativum and SA:
S. aromaticum. MW: Molecular weight markers. Experiment was repeated three times
Fig. 4 Effect of three spices on glycation induced protein cross-linking. SDS-PAGE was conducted using aliquots collected after 6 and 31 days.
a Incubations carried out without fructose (−Fructose) for 6 days. b Incubations carried out with fructose (+Fructose) for 6 days. c Incubations
carried out with fructose (+Fructose) for 31 days. Incubations were conducted in the absence of plant extracts or AG (−P) or presence of CS, CZ and
SA (1 mg/ ml) CS: C. sativum, CZ: C. zeylanicum, SA: S. aromaticum, MW: Molecular weight markers. Experiment was repeated three times
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inhibitory potential (Fig. 5). Reaction mixtures with 5 μg/ml
extracts showed much lower inhibition (Fig. 5).
Detection of glycation induced protein cross-linking
inhibitory potential of spices
High molecular weight products of lysozyme appeared,
when lysozyme was incubated in the presence of fructose
(Figs. 4, 5). These changes did not occur in the absence of
fructose (− Fructose) (Fig. 4a). In the presence of 1 mg/ml
SA and CS, a marked inhibition of protein cross-linking
was observed on day 6 (Fig. 4b). This inhibition was sus-
tained even at 31 days (Fig. 4c). The inhibition observed
with the CZ at 1 mg/ml was comparatively lower at day 6
(Fig. 4b). Extent of cross-linking observed in the presence
of CZ on day 31 was similar to that of uninhibited control.
This suggests the lack of sustainable inhibition with CZ
on protein cross-linking (Fig. 4c).
Lower concentrations of CS and SA were used to inves-
tigate the inhibitory effects further. Protein cross-linking
inhibition was almost complete, even with 25 μg/ml CS
and SA (Fig. 5b). Reaction mixtures with 5 μg/ml extracts
showed much lower inhibition (Fig. 5b).
Discussion
Studies conducted to investigate protein glycation inhibi-
tors have used expensive specialized equipments [9]. Pre-
viously we have optimized a simple SDS-PAGE method
using lysozyme to detect the inhibitory effects of plant ex-
tracts on glycation induced lysozyme cross-linking [10].
Even though the glycation induced protein cross-linking
inhibition by pure compounds has been studied using the
SDS-PAGE method before [12], no reports were available
for its application for crude plant extracts. Being a protein
with a pI of 11.35 and having 6 Lysine residues and 11
Arginine residues which are the targets of glycation, lyso-
zyme serves as a good candidate for glycation induced
protein modifications. Lysozyme showed extensive cross-
linking under the conditions that increase the protein
glycation such as increase in the sugar concentration, in-
cubation period and the reactivity of the sugar [10]. With
SDS-PAGE, products of glycation induced cross-linking
appeared as high molecular weight bands [10]. In the
current study, the extent of cross-linking was compared
by visual observation which gave only an idea about the
approximate inhibition to the cross-link formation. A
more accurate comparison would be achieved with quan-
tification using a gel documentation system.
Methanol extracts were selected in the current study as
they are known to contain negligible amounts of sugars
which, if present, would interfere with the outcome of the
glycation experiments. Antidiabetic plants selected in this
study are being used to treat diabetes since ancient times
and are proven for their hypoglycaemic properties experi-
mentally too [13]. As per up-to-date literature, there are
no previous reports available on the effect of these ten
plants on glycation induced protein cross-linking even
though PE fruit, MP inflorescence and TC bark were stud-
ied for their antiglycation effects. We have demonstrated
cross-link inhibitory potential of the plants tested, using a
relatively simple method established previously [10]. Re-
sistant to cross-link formation (with no much variation
from the respective blanks) was observed in the presence
of extracts of seven antidiabetic plants demonstrating in-
hibitory effects. PD, PE, and PM demonstrated a strong
inhibition to protein cross-link formation at a concentra-
tion as low as 25 μg/ml. Hence, our results suggest the
presence of an additional beneficial effect of these antidia-
betic plants which is likely to prevent chronic diabetic
complications. However, these findings need to be con-
firmed using in vivo experiments. The effect of FR, GS,
MP and TC at concentrations below 2.5 mg/ml was not
evaluated in this study.
Previously we have analyzed antiglycation effects of
the same extracts of nine antidiabetic plants and GL [14]
using a different method in which bovine serum albumin
(BSA) was taken as the model protein [15]. Our previous
findings showed promising antiglycation effects in PD
whole plant, PE fruit and PM latex [14]. Furthermore
extracts of FR stem bark, GS leaf, MP yam and TC leaf
also showed almost complete inhibition of glycation at
2 mg/ ml. Antiglycation effects observed with CG leaf
and SP seed were much lower with a lowest inhibition
observed with GL leaf. All those results on antiglycation
effects tallied with the findings on protein cross-linking
inhibitory effects of the present study. Therefore, when
glycation products detected with PAGE are inhibited,
protein cross-linking also is likely to be inhibited. The
other possibility is that the extracts studied have inhibi-
tory effects at early as well as late stages of glycation
process. Fu et al., revealed that cross-linking can be
inhibited in the presence of metal chelators, sulfhydryl
compounds, antioxidants and AG as they can uncouple
glycation from subsequent cross-linking reactions [16].
Findings of Fu et al., suggest that cross-link formation
can be inhibited even after glycation is commenced.
As per up-to-date literature, there are no reports on
glycation induced protein cross-link inhibitory effects or
antiglycation effects of FR, GS, PD and SP other than
our recent report on antiglycation effects [14]. Among
these four plant parts, evidence for a strong glycation in-
duced cross-link inhibitory effect was obtained for PD
(whole plant) in the present study. Previously a strong in
vitro antiglycation potential was revealed in PE fruit,
with a reduction in fluorescent AGEs when BSA was
used [17, 18]. Our results on cross-linking inhibition
with PE support the findings of previous studies on its
antiglycating effects. Different parts of MP and TC were
studied previously on their antiglycation potential. MP
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(inflorescence) inhibited the formation of fluorescent
AGEs [19]. TC stem extracts showed preventive effects
on diabetic neuropathy in female Wistar rats [20]. Our
results on cross-linking inhibition with MP yam and TC
leaf support previous findings obtained on their antigly-
cating effects with different parts of the two plants.
When glycation process was studied under oxidative
and antioxidative conditions using glucose and rat tail
tendon collagen, it was shown that formation of gly-
coxidation products and cross-linking of collagen were
inhibited under antioxidative conditions even though
glycation was unaffected [16]. A good correlation has
been shown between the free radical scavenging and
antioxidant activities and glycation inhibitory activities
of plant extracts [21, 22]. Previous studies have demon-
strated the free radical scavenging and antioxidant acti-
vities of methanol extract of CG leaf [23], tannin
fraction of FR bark [24], ethanol extract of FR bark [25],
ethanol extract of GS leaf [26], methanol extract of MP
inflorescence [19], ethanol extracts of PE fruit [27, 28],
aqueous extract of PM stem bark [29], ethanol extract of
SP seeds [30]‘ and methanol extract of TC stem [31] in
vitro or in vivo. However, a proper comparison between
the antioxidative effects of nine antidiabetic plants can-
not be made using above data as the solvents used for
extraction and the conditions used to measure the anti-
oxidant effects were different.
Spices have contributed to the taste and flavor of foods
for thousands of years. Although the beneficial effects of
spices have been studied for some time on hypoglycaemic
effects, studies carried out on the likely additional protec-
tive effects against diabetic complications are few. As per
up-to-date literature, there are no reports on the effect of
the CS and SA on glycation induced protein cross-linking.
In one study, the aqueous extract of ginger, cinnamon,
cumin, green tea, lemon, apple, garlic and black pepper
were analyzed on their inhibitory effects on glycation in-
duced protein cross-linking using eye lens soluble protein
as the model protein instead of lysozyme [32]. They re-
vealed 30–80 % inhibition of high molecular weight pro-
duct formation with 1 mg/ml extracts, using SDS-PAGE.
However the images of the gels were not included in this
article [32].
We found evidence for strong glycation induced pro-
tein cross-linking inhibitory effects of CS and SA com-
pared to that of CZ for the first time. Strong inhibition
on protein cross-linking was observed with CS and SA at
25 μg/ml. Inhibition in the presence of CZ at 1 mg/ml
was much lower compared to that of CS and SA and this
inhibition did not sustain for a longer period. We have
shown the inhibitory effects of CS previously at 5 mg/ml
on the glycation induced protein cross-linking while
establishing the method [8]. Results of the present study
with SDS-PAGE method on cross-linking were tallied
with the results we obtained on antiglycation effects of
CS, CZ and SA [33], using a novel PAGE method and
BSA [15].
Some of the spices are rich sources of antioxidants and
hence they are beneficial against various diseases. The
most potent antioxidant activities were found in 50 %
ethanol extracts of cloves and cinnamon, when 24 herbs
and spices were analyzed [21]. A positive correlation
existed between the total phenolic content of the extract
and the glycation inhibitory potential of spices [21].
A few studies showed the antiglycating effects of CS,
CZ and SA using advanced equipment. One study re-
ported the inhibitory effects on formation of fluorescent
AGEs in the presence of ethanol extracts of CS, using
spectrofluorimetry [34]. Nine other herbs and spices
were included in their study. A major polyphenol iso-
lated from CZ is the rutin which is known for its anti-
glycating effects [35]. In an earlier study, the best
antiglycating effects were detected in cinnamon and
clove among five culinary herbs and spices tested, which
included rosemary, ginger and pepper [36]. Methanol
extracts from eight dried spices namely, basil, carda-
mom, cinnamon, cumin, parsely, rosemary, thyme and
turmeric, inhibited glycation of BSA incubated with glu-
cose at various degrees with a high inhibition on forma-
tion of fluorescent AGEs with cinnamon [37]. Aqueous
extract of clove inhibited the formation of fluorescent
AGEs and CML, a biomarker of non florescent AGEs
when BSA was incubated with 500 mM fructose [9].
This study has also demonstrated a potent antioxidant
and free radical scavenging activity in the clove extract
in consistent with the findings of the previous studies.
Clove extract contains gallic acid, quercetin glucoside
and ellagic acid among many polyphenolic compounds
[38] which are known for their antiglycation effects [8].
Ellagic acid inhibited cross-linking of lysozyme in the
presence of 400 mM ribose in a dose-dependent man-
ner, as monitored by SDS-PAGE [12]. A group of re-
searchers suggested that the hydroxyl and superoxide
scavenging activity of clove which eventually reduce the
dicarbonyl intermediates may be contributing to the
glycation inhibitory effects [9].
Hypoglycaemic effects of CS, CZ and SA were pre-
viously shown in vivo using streptozotocin-induced
diabetic rats, diabetic mice, or patients with type 2
DM [39–41]. The antiglycating effects observed with
the plant extracts in our study were independent of
their known hypoglycaemic effects, as the sugar con-
centrations used were similar in the presence and ab-
sence of the plant extracts. This suggests an additional
beneficial effect of these extracts against glycation
induced complications. Further studies are needed to
investigate the efficacy and safety of these extracts in
vivo.
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Conclusions
Using a novel, simple method we have demonstrated a
strong glycation induced protein cross-linking inhibitory
potential in P. debilis whole plant, P. emblica fruit,
P. marsupium latex, C. sativum seed and S. aromaticum
flower bud for the first time. These findings support the
strong antiglycating effects we have demonstrated pre-
viously with these five plants parts and with P. emblica,
C. sativum and S. aromaticum by others using different
methods.
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